De-wei Q. Wu
Taoyuan, TNQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Interferon-alpha selectively signals mitochondrial pore opening to allow mitochondrial RNA release in systemic lupus erythematosus: pathophysiological implications.
Journal: Cell communication and signaling : CCS
Published: January 28, 2026
Induction of LY6E regulates interleukin-1β production, potentially contributing to the immunopathogenesis of systemic lupus erythematosus.
Journal: Cell communication and signaling : CCS
Published: December 10, 2024
USP18 induction regulates immunometabolism to attenuate M1 signal-polarized macrophages and enhance IL-4-polarized macrophages in systemic lupus erythematosus.
Journal: Clinical immunology (Orlando, Fla.)
Published: March 26, 2024
USP18 enhances dengue virus replication by regulating mitochondrial DNA release.
Journal: Scientific reports
Published: July 19, 2023
Author Correction: PAK1 confers chemoresistance and poor outcome in non-small cell lung cancer via β-catenin-mediated stemness.
Journal: Scientific reports
Published: October 24, 2020
Hepatitis B virus X protein promotes tumor invasion and poor prognosis in hepatocellular carcinoma via phosphorylation of paxillin at Serine 178 by activation of the c-Jun NH2-terminal kinase.
Journal: American journal of cancer research
Published: June 01, 2019
Association of nuclear localization of SHP2 and YAP1 with unfavorable prognosis in non-small cell lung cancer.
Journal: Pathology, research and practice
Published: November 23, 2018
PD-L1 confers resistance to EGFR mutation-independent tyrosine kinase inhibitors in non-small cell lung cancer via upregulation of YAP1 expression.
Journal: Oncotarget
Published: August 30, 2017
Dioscin overcome TKI resistance in EGFR-mutated lung adenocarcinoma cells via down-regulation of tyrosine phosphatase SHP2 expression.
Journal: International journal of biological sciences
Published: August 03, 2017
MicroRNA-630 may confer favorable cisplatin-based chemotherapy and clinical outcomes in non-small cell lung cancer by targeting Bcl-2.
Journal: Oncotarget
Published: July 26, 2017
A low microRNA-630 expression confers resistance to tyrosine kinase inhibitors in EGFR-mutated lung adenocarcinomas via miR-630/YAP1/ERK feedback loop.
Journal: Theranostics
Published: July 24, 2017
Last Updated: 09/26/2026